ProCE Banner Activity

Linkage to Care After HBV Diagnosis in Asian Communities in the US

Podcast Episodes
A discussion of barriers to linkage to care after patients in Asian communities are diagnosed with HBV, from the healthcare provider’s and the patient advocate’s perspectives.

Released: November 14, 2022

Expiration: November 13, 2023

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from:

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Faculty Disclosure

Primary Author

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

Professor of Medicine (GI & Hepatology, Liver Transplant)
Professor of Epidemiology & Population Health
(by Courtesy)
Director of Hepatology Clerkship
Faculty Search LENS Advocates,
Stanford Department of Medicine
Faculty Fellow, Stanford Center for Innovation
in Global Health
Member, Stanford Cancer Institute, Maternal &
Child Health Research Institute, & Stanford Bio-C
Stanford, California
Past Chair: HBV SIG, The American Association for the Study of Liver Diseases (AASLD)
28th President: The International Association for the Study of the Liver (IASL)

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD: consultant/advisor/speaker: Exact Science, Gilead, GlaxoSmithKline, Intercept, Laboratory of Advanced Medicine, Lilly; researcher: Exact Science, Gilead, GlaxoSmithKline, Intercept, Laboratory of Advanced Medicine, Lilly.

Melinda Tran

Melinda Tran has no relevant financial relationships to disclose.

Thuan Vu, MD

Thuan Vu, MD, has no relevant financial relationships to disclose.

Jennifer Wild, MS, BSN, RN, OCN

Clinical Nurse – GI Medical Oncology
UCSF Cancer Center
San Francisco, California

Jennifer Wild, MS, BSN, RN, OCN: consultant/advisor/speaker: MUH Life Sciences.